Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Karen Fehn"'
Autor:
Ioannis Mantzaris, Mendel Goldfinger, David Levitz, Kateryna Fedorov, Annemarie Munoz, Nicole Chambers, Karen Fehn, Aradhika Dhawan, Joel Victor, Nishi Shah, Aditi Shastri, Noah Kornblum, Alejandro Sica, Kira Gritsman, Dennis Cooper, Mimi Kim, Amit K. Verma, Ulrich Steidl, Eric Feldman, Marina Konopleva
Publikováno v:
HemaSphere, Vol 7, p e46119b8 (2023)
Externí odkaz:
https://doaj.org/article/9f89dfd25cfc448187db46e647f1e651
Autor:
Sakshi Jasra, Mohammed Kazemi, Nishi Shah, Jiahao Chen, Karen Fehn, Yanhua Wang, Ioannis Mantzaris, Noah Kornblum, Alejandro Sica, LizaMarie Bachier, Mendel Goldfinger, Kira Gritsman, Ira Braunschweig, Ulrich Steidl, Aditi Shastri, Amit Verma
Publikováno v:
Experimental Hematology & Oncology, Vol 10, Iss 1, Pp 1-4 (2021)
Abstract Optimal treatment of acute myeloid leukemia (AML) arising in elderly patients remains a challenge. FDA approval of Ivosidenib and Enasidenib, small molecule inhibitors of isocitrate dehydrogenase enzymes (IDH1 and 2) have opened new avenues
Externí odkaz:
https://doaj.org/article/7b18812b0b844ab9876c76ff71de96d7
Autor:
Kateryna Fedorov, Tanim Jain, Kith Pradhan, Jennat Mustafa, Amanda Lombardo, Fariha Khatun, Felisha Joseph, Kailyn Gillick, Anjali Naik, Richard Elkind, Karen Fehn, Alyssa de Castro, Roy Browne, Michelly Abreu, Donika Binakaj, Monika Paroder, Carlo Palesi, Kira Gritsman, R Alejandro Sica, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Nishi Shah, Amit Verma, Ira Braunschweig, Mendel Goldfinger
Publikováno v:
Haematologica, Vol 107, Iss 9 (2022)
Externí odkaz:
https://doaj.org/article/b68e1ebb6ef1462f834168c164e784cd
Autor:
Ahmed Abbasi, Stephen Peeke, Nishi Shah, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Michelly Abreu, Richard Elkind, Karen Fehn, Alyssa de Castro, Yanhua Wang, Olga Derman, Randin Nelson, Joan Uehlinger, Kira Gritsman, R. Alejandro Sica, Noah Kornblum, Ioannis Mantzaris, Aditi Shastri, Murali Janakiram, Mendel Goldfinger, Amit Verma, Ira Braunschweig, Lizamarie Bachier-Rodriguez
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-4 (2020)
Abstract Axicabtagene ciloleucel (Axi-cel) is a CD-19 Chimeric Antigen Receptor T cell therapy approved for the treatment of relapsed/refractory diffuse large B cell lymphoma. We treated ten patients with DLBCL post-FDA approval in an inner-city tert
Externí odkaz:
https://doaj.org/article/305b79557508473a87fe220da1993f4a
Autor:
Hyun ah Yoon, Rachel Bartash, Inessa Gendlina, Johanna Rivera, Antonio Nakouzi, Robert H. Bortz III, Ariel S. Wirchnianski, Monika Paroder, Karen Fehn, Leana Serrano-Rahman, Rachelle Babb, Uzma N. Sarwar, Denise Haslwanter, Ethan Laudermilch, Catalina Florez, M. Eugenia Dieterle, Rohit K. Jangra, J. Maximilian Fels, Karen Tong, Margarette C. Mariano, Olivia Vergnolle, George I. Georgiev, Natalia G. Herrera, Ryan J. Malonis, Jose A. Quiroz, Nicholas C. Morano, Gregory J. Krause, Joseph M. Sweeney, Kelsie Cowman, Stephanie Allen, Jayabhargav Annam, Ariella Applebaum, Daniel Barboto, Ahmed Khokhar, Brianna J. Lally, Audrey Lee, Max Lee, Avinash Malaviya, Reise Sample, Xiuyi A. Yang, Yang Li, Rafael Ruiz, Raja Thota, Jason Barnhill, Doctor Y. Goldstein, Joan Uehlinger, Scott J. Garforth, Steven C. Almo, Jonathan R. Lai, Morayma Reyes Gil, Amy S. Fox, Kartik Chandran, Tao Wang, Johanna P. Daily, Liise-anne Pirofski
Publikováno v:
JCI Insight, Vol 6, Iss 4 (2021)
Convalescent plasma with severe acute respiratory disease coronavirus 2 (SARS-CoV-2) antibodies (CCP) may hold promise as a treatment for coronavirus disease 2019 (COVID-19). We compared the mortality and clinical outcome of patients with COVID-19 wh
Externí odkaz:
https://doaj.org/article/0358cbc15a254f3fab654810aaab2594
Autor:
Jesus D. Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, William B. Donnellan, Jesus Berdeja, Prafulla Bhagat, Karen Fehn, Cassady Remy, Sakshi Jasra, Mohammed Kazemi, Kith Pradhan, Mimi Kim, Ioannis Mantzaris, R. Alejandro Sica, Nishi Shah, Mendel Goldfinger, Noah Kornblum, Kira Gritsman, Ira Braunschweig, Ulrich Steidl, Britta Will, Aditi Shastri, Amit Verma
Publikováno v:
Clinical Cancer Research. 29:60-66
Purpose: Thrombocytopenia is a serious complication of myelodysplastic syndromes (MDS) associated with an increased bleeding risk and worse prognosis. Eltrombopag (ELT), a thrombopoietin receptor agonist, can increase platelet counts and reverse anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0404ea6f82157e541783874a978241b5
https://doi.org/10.1158/1078-0432.ccr-22-1457
https://doi.org/10.1158/1078-0432.ccr-22-1457
Autor:
Amit Verma, Aditi Shastri, Britta Will, Ulrich Steidl, Ira Braunschweig, Kira Gritsman, Noah Kornblum, Mendel Goldfinger, Nishi Shah, R. Alejandro Sica, Ioannis Mantzaris, Mimi Kim, Kith Pradhan, Mohammed Kazemi, Sakshi Jasra, Cassady Remy, Karen Fehn, Prafulla Bhagat, Jesus Berdeja, William B. Donnellan, Abdulraheem Yacoub, Suman Kambhampati, Jesus D. Gonzalez-Lugo
Supplemental Figure 1. Overall Survival Responders vs Non-Responders Supplemental Figure 2. Overall Survival Among Groups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3cf496686dd19fa5b10d5494cc344ad
https://doi.org/10.1158/1078-0432.22489251
https://doi.org/10.1158/1078-0432.22489251
Autor:
Amit Verma, Aditi Shastri, Britta Will, Ulrich Steidl, Ira Braunschweig, Kira Gritsman, Noah Kornblum, Mendel Goldfinger, Nishi Shah, R. Alejandro Sica, Ioannis Mantzaris, Mimi Kim, Kith Pradhan, Mohammed Kazemi, Sakshi Jasra, Cassady Remy, Karen Fehn, Prafulla Bhagat, Jesus Berdeja, William B. Donnellan, Abdulraheem Yacoub, Suman Kambhampati, Jesus D. Gonzalez-Lugo
Purpose:Thrombocytopenia is a serious complication of myelodysplastic syndromes (MDS) associated with an increased bleeding risk and worse prognosis. Eltrombopag (ELT), a thrombopoietin receptor agonist, can increase platelet counts and reverse anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d2220d250a4f0d48965425b1d6c76cc
https://doi.org/10.1158/1078-0432.c.6532914.v1
https://doi.org/10.1158/1078-0432.c.6532914.v1
Autor:
Jesus D, Gonzalez-Lugo, Suman, Kambhampati, Abdulraheem, Yacoub, William B, Donnellan, Jesus, Berdeja, Prafulla, Bhagat, Karen, Fehn, Cassady, Remy, Sakshi, Jasra, Mohammed, Kazemi, Kith, Pradhan, Mimi, Kim, Ioannis, Mantzaris, R Alejandro, Sica, Nishi, Shah, Mendel, Goldfinger, Noah, Kornblum, Kira, Gritsman, Ira, Braunschweig, Ulrich, Steidl, Britta, Will, Aditi, Shastri, Amit, Verma
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research.
Thrombocytopenia is a serious complication of MDS associated with an increased bleeding risk and worse prognosis. Eltrombopag (ELT), a thrombopoietin receptor agonist, can increase platelet counts and reverse anti-megakaryopoietic effects of lenalido
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::103d2e99cdc4bb03816a9caa11ac89bd
https://pubmed.ncbi.nlm.nih.gov/36255372
https://pubmed.ncbi.nlm.nih.gov/36255372
Autor:
Ioannis Mantzaris, Mendel Goldfinger, David Levitz, Kateryna Fedorov, Karen Fehn, Nicole Chambers, Anne Munoz, Aradhika Dhawan, Joel Victor, Nishi Shah, Aditi Shastri, Noah Kornblum, R. Alejandro Sica, Kira Gritsman, Dennis Cooper, Mimi Kim, Evripidis Gavathiotis, Marina Konopleva, Amit Verma, Eric J. Feldman, Ulrich G. Steidl
Publikováno v:
Blood. 140:3360-3361
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18bc30a58c56f6ae0b67605a75ed2575
https://doi.org/10.1182/blood-2022-167849
https://doi.org/10.1182/blood-2022-167849